Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models

Current Eye Research

Volumn 40, Issue 10, 2015, Pages 990-1000

  Nagai, Noriaki ^a   Yoshioka, Chiaki ^a   Mano, Yu ^a   Ito, Yoshimasa ^a   Okamoto, Norio ^b   Shimomura, Yoshikazu ^b  

^a KINKI UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Disulfiram; glaucoma; kinetic analysis; methylcellulose; nitric oxide

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DISULFIRAM; EYE DROPS; GLUCOSE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; NITRIC OXIDE; TIMOLOL MALEATE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; DRUG COMBINATION; DRUGS USED IN THE TREATMENT OF ADDICTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; AREA UNDER THE CURVE; AREA UNDER THE MOMENT CURVE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MEAN RESIDENCE TIME; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; ANIMAL; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; METABOLISM; OCULOPLETHYSMOGRAPHY; RABBIT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ALCOHOL DETERRENTS; ANIMALS; AQUEOUS HUMOR; BETA-CYCLODEXTRINS; DISEASE MODELS, ANIMAL; DISULFIRAM; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; HYPROMELLOSE DERIVATIVES; INTRAOCULAR PRESSURE; MALE; METHYLCELLULOSE; NITRIC OXIDE; OPHTHALMIC SOLUTIONS; RABBITS; TONOMETRY, OCULAR;

EID: 84941414459     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.971187     Document Type: Article

References (34)

1. Armaly MF, Krueger DE, Maunder L, Becker B, Hetherington Jr J, Kolker AE, et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol 1980;98:2163-2171.
2. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-649.
3. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-393.
4. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005;46: 175-182.
5. Osborne NN, Barnett NL, Herrera A. NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. J Brain Res 1993; 610:194-198.
6. Nathanson JA, McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Ophthalmol Vis Sci 1995;36:1765-1773.
7. Meyer P, Champion C, Schlotzer SU, Flammer J, Haefliger IO. Localization of nitric oxide synthase isoforms in porcine ocular tissues. Curr Eye Res 1999;18:375-380.
8. Wiederholt M, Sturm A, Lepple WA. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci 1994;35:2515-2520.
9. Goh Y, Hotehama Y, Mishima HK. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest Ophthalmol Vis Sci 1995;36:1188-1192.
10. Kiel JW, Reitsamer HA, Walker JS, Kiel FW. Effects of nitric oxide synthase inhibition on ciliary blood flow, production and intraocular pressure. Exp Eye Res 2001;73:355-364.
11. Ito Y, Nagai N, Shimomura Y. Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-b-cyclodextrin in rabbit. Biol Pharm Bull 2010;33:1574-1578.
12. Rall TW. Hypnotics and sedatives; ethanol. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1990. pp 378-379.
13. Ito Y, Cai H, Koizumi Y, Nakao M, Terao M. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats. Curr Eye Res 1999;18:292-299.
14. Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 1997;86:147-162.
15. Muller BW, Brauns U. Solubilization of drugs by modified b-cyclodextrins. Int J Pharm 1985;26:77-2688.
16. Kristinsson JK, Fridriksdottir H, Thorisdottir S, Sigurdardottir AM, Stefansson E, Loftsson T. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest Ophthalmol Vis Sci 1996;37:1199-1203.
17. Wang S, Li D, Ito Y, Liu X, Zhang J, Wu C. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex-corneal permeability, anti-cataract effects and mechanism studies. J Pharm Pharmacol 2004;56:1251-1257.
18. Nagai N, Takeda M, Ito Y, Takeuchi N, Kamei A. Delay in ICR/f rat lens opacification by the instillation of eyedrops containing disulfiram and hydroxypropyl-betacyclodextrin inclusion complex. Biol Pharm Bull 2007;30: 1529-1534.
19. Nagai N, Ito Y, Takeuchi N. Effect of disulfiram eye drops on lipid peroxide formation via excessive nitric oxide in lenses of hereditary cataract ICR/f rats. Biol Pharm Bull 2008;31:981-985.
20. Bonomi L, Tomazzoli L, Jaria D. An improved model of experimentally induced ocular hypertension in the rabbit. Invest Ophthalmol 1976;15:781-784.
21. Lin CP, Boehnke M. Influences of methylcellulose on corneal epithelial wound healing. J Ocul Pharmacol Ther 1999;15:59-63.
22. Saarinen SP, Jarvinen T, Araki SK, Watanabe H, Urtti A. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res 1998;15: 1275-1280.
23. Jansen T, Xhonneux B, Mesens J, Borgers M. Betacyclodextrins as vehicles in eye-drop formulations: An evaluation of their effects on rabbit corneal epithelium. Lens Eye Toxic Res 1990;7:459-468.
24. Nagai N, Ito Y, Takeuchi N. Pharmacokinetic and pharmacodynamic evaluation of the anti-cataract effect of eye drops containing disulfiram and low-substituted methylcellulose using ICR/f rats as a hereditary cataract model. Biol Pharm Bull 2012;35:239-245.
25. King G, Holmes R. Human ocular aldehyde dehydrogenase isozymes: distribution and properties as major soluble proteins in cornea and lens. J Exp Zool 1998;282:12-17.
26. Nagai N, Inomata M, Ito Y. Contribution of aldehyde dehydrogenase 3A1 to disulfiram penetration through monolayers consisting of cultured human corneal epithelial cells. Biol Pharm Bull 2008;31:444-448.
27. Schultz GS, Davis JB, Eiferman RA. Growth factors and corneal epithelium. Cornea 1988;7:96-101.
28. Shah GB, Sharma S, Mehta AA, Goyal RK. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000;36:169-175.
29. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res 1999;69:413-429.
30. Rowland JM, Potter DE, Reiter RJ. Circadian rhythm in intraocular pressure: A rabbit model. Curr Eye Res 1981;1: 169-173.
31. Gregory DS, Aviado DG, Sears ML. Cervical ganglionectomy alters the circadian rhythm of intraocular pressure in New Zealand White rabbits. Curr Eye Res 1985;4: 1273-1279.
32. Rowland JM, Sawyer WK, Tittel J, Ford CJ. Studies on the circadian rhythm of IOP in rabbits: correlation with aqueous inflow and cAMP content. Curr Eye Res 1986;5: 201-206.
33. McLaren JW, Trocme SD, Relf S, Brubaker RF. Rate of flow of aqueous humor determined from measurements of aqueous flare. Invest Ophthalmol Vis Sci 1990;31: 339-346.
34. Smith SD, Gregory DS. A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits. Invest Ophthalmol Vis Sci 1989;30: 775-778.